US Congress Senate Bill 523 (Prior Session Legislation)

---

Spectrum: Strong Partisan Bill (Democrat 12-1)
Status: Introduced on March 2 2017 - 25% progression, died in committee
Action: 2017-03-02 - Read twice and referred to the Committee on Finance.
Pending: Senate Finance Committee
Text: Latest bill text (Introduced) [PDF]

Budgeting for Opioid Addiction Treatment Act This bill amends the Internal Revenue Code, with respect to excise taxes on manufacturers, to impose a one cent per milligram fee on the sale of active opioids by the manufacturer, producer, or importer. The fee excludes prescription drugs used exclusively for the treatment of opioid addiction as part of a medically assisted treatment effort. The Department of Health and Human Services (HHS) must establish a program to provide rebates or discounts to cancer and hospice patients to ensure that they do not pay the fee. The bill amends the Public Health Service Act to require any increase in federal revenues from the fee after rebates and discounts are subtracted to be distributed to states under the Substance Abuse Prevention and Treatment Block Grant program. The states must use the funds exclusively for substance abuse (including opioid abuse) efforts in the states, including: (1) specified treatment programs, and (2) the recruitment and training of substance use disorder professionals to work in rural and medically underserved communities. HHS must report to Congress on the impact of this bill on the retail cost of opioids and patient access to opioid medication, the effectiveness of the discount or rebate for cancer and hospice patients, how the funds are being used to improve substance abuse treatment efforts, and suggestions for improving access to opioids for cancer and hospice patients and substance abuse treatment efforts.

Budgeting for Opioid Addiction Treatment Act

Sen. Joe Manchin [D-WV]	Sen. Amy Klobuchar [D-MN]	Sen. Heidi Heitkamp [D-ND]	Sen. Bill Nelson [D-FL]
Sen. Angus King [I-ME]	Sen. Christopher Murphy [D-CT]	Sen. Tammy Baldwin [D-WI]	Sen. Elizabeth Warren [D-MA]
Sen. Margaret Hassan [D-NH]	Sen. Jeanne Shaheen [D-NH]	Sen. Richard Blumenthal [D-CT]	Sen. Sheldon Whitehouse [D-RI]
Sen. Tina Smith [D-MN]

Date	Chamber	Action
2017-03-02	Senate	Read twice and referred to the Committee on Finance.

HB2038 (Same As) 2017-04-07 - Referred to the Subcommittee on Health.

Type	Source
Summary	https://www.congress.gov/bill/115th-congress/senate-bill/523/all-info
Text	https://www.congress.gov/115/bills/s523/BILLS-115s523is.pdf